Trials / Enrolling By Invitation
Enrolling By InvitationNCT04677699
Combined Antibody Screening for Celiac and Diabetes Evaluation
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 64,410 (estimated)
- Sponsor
- Pacific Northwest Research Institute · Academic / Other
- Sex
- All
- Age
- 1 Day – 7 Years
- Healthy volunteers
- Accepted
Summary
The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an observational study whose primary goal is to show that population-based screening for advanced prediction of type 1 diabetes (T1D) and celiac disease (CD) is feasible to prevent diabetic ketoacidosis (DKA), improve celiac disease diagnosis, and ultimately gain public health acceptance to facilitate future prevention. It has two arms, a Birth Cohort and a Kids (cross sectional) Cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Combined Risk Score | Several factors will be analyzed to assign each subject combined risk score. This will assess the subject's risk of developing Type 1 Diabetes and/or Celiac Disease. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-12-01
- Completion
- 2026-06-01
- First posted
- 2020-12-21
- Last updated
- 2020-12-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04677699. Inclusion in this directory is not an endorsement.